Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INTRA-CELLULAR THERAPIES, INC.

(ITCI)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-03 pm EST
48.92 USD   -1.65%
01/13RBC Cuts Price Target on Intra-Cellular Therapies to $72 From $74, Maintains Outperform Rating
MT
01/09Intra-cellular Therapies, Inc. : Entry into a Material Definitive Agreement (form 8-K)
AQ
01/09Transcript : Intra-Cellular Therapies, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 11:15 AM
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart INTRA-CELLULAR THERAPIES, INC.
Upcoming events on INTRA-CELLULAR THERAPIES, INC.
03/01/23 FY 2022 Earnings Release (Projected)
05/10/23 Q1 2023 Earnings Release (Projected)
08/09/23 Interim 2023 Earnings Release (Projected)
11/08/23 Q3 2023 Earnings Release (Projected)
Past events on INTRA-CELLULAR THERAPIES, INC.
01/09/23 | 02:15pm JP Morgan Healthcare Conference
11/29/22 | 12:35pm Evercore ISI HealthCONx Conference
11/14/22 J.P. Morgan Equity Opportunities Forum
11/03/22 | 07:30am Q3 2022 Earnings Call
11/03/22 | 06:30am Q3 2022 Earnings Release
08/09/22 | 08:30am Interim 2022 Earnings Call
08/09/22 | 07:30am Interim 2022 Earnings Release
06/11/22 International Society for Bipolar Disorders Conference - Lumateperone
06/11/22 International Society for Bipolar Disorders Conference - Effect of Lumateperone
06/11/22 International Society for Bipolar Disorders Conference - Metabolic Syndrome
Past dividends on INTRA-CELLULAR THERAPIES, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
0,25
0,27
-8,4%


 
0,06

 
22,8
22,3
2,5%
83,8
83,1
0,84%
 
249
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-103
-102
-1,00%
-162
-174
7,0%
-154
-155
0,68%
-231
-240
4,0%
-285
-284
-0,44%
 
-276
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-103
-98,5
-4,4%
-162
-170
4,8%
-154
-159
3,3%
-231
-237
2,6%
-286
-282
-1,3%
 
-274
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-98,8
-96,8
-2,1%
-155
-165
6,0%
-148
-152
2,7%
-227
-236
3,8%
-284
-282
-0,70%
 
-272
 
Net income
M $
Released
Forecast
Spread
-97,8
-94,3
-3,6%
-155
-164
5,6%
-148
-151
2,5%
-227
-234
2,9%
-284
-282
-0,74%
 
-270
 
EPS
$
Released
Forecast
Spread
-2,12
-2,07
-2,3%
-2,84
-3,00
5,4%
-2,68
-2,74
2,3%
-3,23
-3,34
3,3%
-3,50
-3,45
-1,3%
 
-2,87
 
Announcement Date03/01/201802/27/201903/02/202002/25/202103/01/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread
22,2
22,1
0,42%
25,7
25,0
2,6%
35,0
33,5
4,4%
55,6
48,6
14%
71,9
66,0
8,9%
 
87,0
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-77,1
-77,8
0,87%
-85,9
-87,8
2,2%
-72,5
-85,3
15%
-87,8
-78,3
-12%
-55,5
-83,9
34%
 
-71,0
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-77,3
-75,8
-2,0%
-86,0
-82,3
-4,5%
-72,7
-84,0
13%
-87,9
-70,7
-24%
-55,6
-77,3
28%
 
-57,3
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-76,9
-72,7
-5,8%
-85,7
-83,8
-2,3%
-72,1
-88,7
19%
-86,6
-73,8
-17%
-53,5
-82,9
35%
 
-59,1
 
Net income
M $
Released
Forecast
Spread
-76,9
-74,7
-2,9%
-85,7
-83,4
-2,8%
-72,1
-85,8
16%
-86,6
-72,6
-19%
-53,5
-77,3
31%
 
-57,5
 
EPS
$
Released
Forecast
Spread
-0,95
-0,91
-3,8%
-1,05
-1,00
-4,6%
-0,78
-0,93
16%
-0,92
-0,77
-19%
-0,57
-0,82
31%
 
-0,60
 
Announcement Date11/09/202103/01/202205/10/202208/09/202211/03/2022-
Previous year Next Year
Upcoming sector events for INTRA-CELLULAR THERAPIES, INC.
More events
Past sector events for INTRA-CELLULAR THERAPIES, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise